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The Royal Infirmary, Edinburgh EH3 9YW, UK European Journal of Gastroenterology & Hepatology 2010, 22:638-641 Proton-pump inhibitor use is not associated with osteoporosis or accelerated bone mineral density loss Laura E. Targownik, Lisa M. LixStella Leung, William D. Leslie. Backgrounds and aims: Recent studies have shown an association between proton-pump inhibitor use (PPI) and hip fracture. The mechanism by which PPI use promotes the development of hip fracture is uncharacterized. Therefore, we sought to determine whether PPI use is associated with osteoporosis or accelerated bone mineral density (BMD) loss.
Methods: We used the Manitoba Bone Mineral Density Database to determine the relationship between chronic PPI use and osteoporosis on an initial assessment of BMD and on BMD loss between successive assessments of BMD. In the cross-sectional study, cases with osteoporosis at the hip or lumbar vertebrae (T-score r -2.5) were matched to 3 controls with normal BMD (T-score Z -1.0). In the longitudinal analysis, the change in BMD among PPI users and nonusers between successive BMD assessments was assessed. Conditional logistic regression and multivariate linear regression were used to obtain estimates of the association between PPI use and osteoporosis and of the annualized change in BMD associated with PPI use.
Results: PPI use was not associated with having osteoporosis at either the hip (OR, 0.84; 95% CI, 0.55-1.34) or the lumbar spine (OR, 0.79; 95% CI, 0.59-1.06) for PPI use > 1500 doses over the previous 5 years. In the longitudinal study no significant decrease was observed in BMD at either site attributable to PPI use.
Conclusion: PPI use does not appear to be associated with either the presence of osteoporosis or accelerated BMD loss. The association between PPI use and hip fracture is probably related to factors independent of osteoporosis. Objectives: The standard approach to benign esophageal perforations consists of conservative treatment or surgery. In this study, we investigated the efficacy of short-term stent placement for nonmalignant esophageal perforations.
Methods: This is a prospective single-center study of patients with benign esophageal perforations in whom a removable self-expandable stent was placed. Data were collected from a prospective database, endoscopy records, and operation reports. To obtain follow-up data, we contacted the patients, their relatives, or their general practitioner.
Results: A total of 33 patients underwent stent insertion owing to an iatrogenic perforation (n = 19), Boerhaave's syndrome (n = 10), or other causes (n = 4); this resulted in an immediate and complete sealing of the lesion in 32 patients (97%). Stents migrated in 11 patients (33%). Four patients required an esophageal resection for failed stent therapy (n = 3) and failed stent removal (n = 1). The 90day mortality rate was 15%. A total of 33 endoscopic stent extractions were attempted. Overall, 23 stents were extracted within 6 weeks (group I) and 10 stents between 6 and 84 weeks (group II). Extractions were uncomplicated in all patients in group I (100%) versus in 5 patients in group II (50%) (P = 0.001). Six extraction-related complications occurred in group II, including two self-limiting bleedings, three stent fractures, and one impacted stent.
Conclusion:
In patients with a benign esophageal perforation, temporary stent therapy is effective and provides a good alternative to surgery. Complications due to stent removal can be prevented by removal of the prosthesis within 6 weeks after insertion, without compromising the efficacy of treatment. The position of the acid pocket as a major risk factor for acidic reflux in healthy subjects and patients with GORD Hanneke Beaumont, Roelof J Bennink, Jan de Jong, Guy E Boeckxstaens Introduction: Gastro-oesophageal reflux occurs twice as much during transient lower oesophageal sphincter relaxations (TLOSRs) in patients with gastro-oesophageal reflux disease (GORD) compared to healthy volunteers (HVs). Our aim was to assess whether the localisation of the postprandial acid pocket and its interaction with a hiatal hernia (HH) play a role in the occurrence of acidic reflux during TLOSRs.
Methods: Ten HVs and 22 patients with GORD [12 with HH < 3 cm (s-HH), 10 with HH Z 3 cm (l-HH)] were studied. The squamocolumnar junction and diaphragmatic impression were marked with a radioactively labelled clip. To visualise the acid pocket, 99m Tc-pertechnetate was injected intravenously and images were acquired up to 2 h postprandial. Concurrently, combined manometry/ impedance and four-channel pH-metry were performed, with pH pull-through at multiple time-points.
Results: The rate of TLOSRs and the per cent associated with reflux was comparable between all groups. However, acidic reflux was significantly increased in patients, especially in patients with l-HH. Acid pocket length was significantly enlarged in patients. Moreover, immediately before a TLOSR, the acid pocket was more frequently located within the hiatus or above the diaphragm in patients with GORD (s-HH, 54%; l-HH, 77%) compared to HVs (22% of TLOSRs). Acidic reflux was significantly increased when the acid pocket was located above the diaphragm in all groups compared to a subdiaphragmatic localisation.
Conclusion: The position of the acid pocket is largely determined by the presence of a HH. Entrapment of the pocket above the diaphragm, especially in patients with l-HH, is a major risk factor underlying the increased occurrence of acidic reflux during a TLOSR in patients with GORD. Gut 2010; 59:441-451. doi:10.1136 /gut.2009 Colonoscopy withdrawal time and risk of neoplasia at 5 years: results from VA cooperative studies program 380
Ziad F Gellad, David G Weiss Dennis J Ahnen, David A Lieberman, George L Jackson, Dawn Provenzale Objectives: Withdrawal time (WT) has been proposed as a quality indicator for colonoscopy based on evidence that it is directly related to the rate of adenoma detection.
Our objective was to test the hypothesis that baseline WT is inversely associated with the risk of finding neoplasia at interval colonoscopy.
Methods: In all, 3121 subjects, aged 50-75 years, had screening colonoscopy between 1994 and 1997 at 13 Veteran Affairs Medical Centers. In all, 1193 subjects returned by protocol for surveillance within 5.5 years. In the 304 patients without polyps at baseline, we evaluated the contribution of baseline WT to their risk of interval neoplasia using bivariate and logistic regression analysis. We also examined the correlation between mean WT, baseline adenoma detection rate, and interval neoplasia rate at the medical-center level.
Results:
The average WT at the baseline exam in subjects with neoplasia on follow-up was 15.3 min as compared with 13.2 min in subjects without neoplasia (P = 0.18). In a logistic regression model, WT was not associated with the risk of interval neoplasia (P = 0.07). At the medicalcenter level, mean WT was not correlated with the probability of finding interval neoplasia (P = 0.61) but was positively correlated with adenoma detection rate at baseline (P = 0.03).
Conclusion:
In this study with a mean baseline WT and 12 min, there was no detectable association between WT and risk of future neoplasia. The medical center-level WT was positively correlated with adenoma detection. Therefore, above a certain threshold, WT may no longer be an adequate quality measure for screening colonoscopy.
Am J Gastroenterol advance online publication, 2010; doi:10.1038/ajg.2010.107.
Noninvasive markers of liver fibrosis are highly predictive of liver-related death in a cohort of HCV-infected individuals with and without HIV infection with two established prognostic scores, the Child-Pugh-Turcotte (CPT) and model of end-stage liver disease (MELD) scores.
Results: A total of 303 subjects, of whom 207 were HIV positive at study entry, were followed up for a mean period of 3.1 years. There were 33 deaths due to liver disease. The ability of each test and score to predict 3year liver mortality was expressed as the area under the receiver operator curve. The area under the receiver operator curve 95% confidence intervals were: HA 0.92 (0.86-0.96), CPT 0.91 (0.79-0.96), APRI 0.88 (0.80-0.93), Fib-4 0.87 (0.77-0.92), MELD 0.84 (71-0.91). In multivariate analyses HA, APRI, and fib-4 were independent predictors of mortality when included in models with MELD or CPT.
Conclusion: Noninvasive markers of liver fibrosis are highly predictive of liver outcome in HCV-infected individuals with and without HIV coinfection. These markers seem to have a prognostic value independent of CPT and MELD.
Am J Gastroenterol 2010 [Epub ahead of print].
Genome-wide association analysis in primary sclerosing cholangitis
Karlsen T.H., Franke A., Melum E., Kaser A., Hov J.R., Balschun T., Lie B.A., Bergquist A., Schramm C., Weismu¨ller T.J., Gotthardt D., Rust C., Philipp E.E., Fritz T., Henckaerts L., Weersma R.K., Stokkers P., Ponsioen C.Y., Wijmenga C., Sterneck M., Nothnagel M., Hampe J., Teufel A., Runz H., Rosenstiel P., Stiehl A., Vermeire S., Beuers U., Manns M.P., Schrumpf E., Boberg K.M., Schreiber S.
Background and aims:
We aimed to characterize the genetic susceptibility to primary sclerosing cholangitis (PSC) by means of a genome-wide association analysis of single nucleotide polymorphism (SNP) markers.
Methods: A total of 443 816 SNPs on the Affymetrix SNP Array 5.0 (Affymetrix, Santa Clara, CA) were genotyped in 285 Norwegian PSC patients and 298 healthy controls. Associations detected in this discovery panel were reexamined in independent case-control panels from Scandinavia (137 PSC cases and 368 controls), Belgium/ The Netherlands (229 PSC cases and 735 controls), and Germany (400 cases and 1832 controls).
Results:
The strongest associations were detected near HLA-B at chromosome 6p21 [rs3099844: odds ratio (OR), 4.8; 95% confidence interval (CI), 3.6-6.5; P = 2.6 Â 10 -26 ; and rs2844559: OR, 4.7; 95% CI, 3.5-6.4; P = 4.2 Â10 -26 in the discovery panel]. Outside the HLA complex, rs9524260 at chromosome 13q31 showed significant associations in 3 of 4 study panels. Lentiviral silencing of glypican 6, encoded at this locus, led to the up-regulation of proinflammatory markers in a cholangiocyte cell line. Of 15 established ulcerative colitis susceptibility loci, significant replication was obtained at chromosomes 2q35 and 3p21 (rs12612347: OR, 1.26; 95% CI, 1.06-1.50; and rs3197999: OR, 1.22; 95% CI, 1.02-1.47, respectively), with circumstantial evidence supporting the G-protein-coupled bile acid receptor 1 and macrophage-stimulating 1, respectively, as the likely disease genes. Liver stiffness measurement (LSM) based on transient elastography (TE, FibroScan) is gaining in popularity for noninvasive assessment of liver fibrosis. However, LSM has limitations, which have not yet been thoroughly evaluated. We prospectively investigated the frequency and determinants of LSM failure and unreliable results over a 5-year period, based on 13 369 examinations (134 239 shots). LSM failure was defined as zero valid shots, and unreliable examinations were defined as fewer than 10 valid shots, an interquartile range (IQR)/LSM greater than 30%, or a success rate less than 60%. LSM failure occurred in 3.1% of all examinations [4% at first examination (n = 7261)] and was independently associated at first examination with body mass index (BMI) greater than 30 kg/m 2 [odds ratio (OR), 7.5; 95% confidence interval (CI), 5.6-10.2; P = 0.0001], operator experience fewer than 500 examinations [OR, 2.5 (1.6-4.0); P = 0.0001]; age greater than 52 years [OR, 2.3 (1.6-3.2); P = 0.0001], and type 2 diabetes [OR, 1.6 (1.1-2.2); P = 0.009]. Unreliable results were obtained in a further 15.8% of cases (17% at first examination) and were independently associated at first examination with BMI greater than 30 kg/m 2 [OR, .0); P = 0.0001], operator experience fewer than 500 examinations [OR, 3.1 (2.4-3.9); P = 0.0001], age greater than 52 years [OR, 1.8 (1.6-2.1); P = 0.0001], female sex [OR 1.4 (1.2-1.6), P = 0.0001], hypertension [OR, 1.3 (1.1-1.5); P = 0.003], and type 2 diabetes [OR, 1.2 (1.0-1.5); P = 0.05]. When metabolic syndrome and waist circumference were taken into account in a subgroup of 2835 patients, waist circumference was the most important determinant of LSM failure and unreliable results.
Conclusion: In our experience, liver stiffness measurements are uninterpretable in nearly one in five cases. The principal reasons are obesity, particularly increased waist circumference, and limited operator experience. These results emphasize the need for adequate operator training and for technological improvements in specific patient subpopulations.
Hepatology 2010; 51:828-835.
Emergency adult-to-adult living-donor liver transplantation for acute liver failure in a hepatitis B virus endemic area Soo Jung Park, Young-Suk Lim, Shin Hwang, Nae Yun Heo, Han Chu Lee, Dong Jin Suh, Eunsil Yu, Sung Gyu Lee
The outcomes of patients with acute liver failure (ALF) vary greatly according to etiology. Emergency adult-toadult living-donor liver transplantation (adult LDLT) would help address the shortage of available organs for patients with ALF, especially in hepatitis B virus (HBV)endemic areas. We analyzed a prospective database of 110 consecutive adult patients with ALF. ALF was defined as sudden development of severe coagulopathy and encephalopathy within 26 weeks of onset of symptoms. In about 90% of patients, ALF was caused by etiologies that usually result in poor outcomes, including HBV infection (37%). Three cases (3%) were associated with acetaminophen overdose. Of the 99 patients listed for emergency liver transplantation, four (4%) underwent deceased-donor liver transplantation (DDLT), and 40 (40%) underwent adult LDLT. The 1-year survival rate of adult LDLT patients was 85%. Of the 55 patients listed but not transplanted, 45 (82%) died within a median of 7 days (range, 1-90 days). Multivariate analysis showed that adult LDLT [hazard ratio (HR) 0.10, P < 0.01] and DDLT (HR, 0.12, P = 0.04) were associated with decreased mortality, whereas older age (HR, 1.03, P = 0.01) and higher Model for End-stage Liver Disease (MELD) (HR 1.03, P = 0.04) was associated with increased mortality of patients. There was no living donor mortality. Eight (17.8%) and three (6.7%) living donors experienced grade 1 and 2 complications, respectively.
Conclusion: Emergency adult LDLT can be performed expeditiously and safely for patients with ALF, and greatly improves the survival rate. As the window during which transplantation is possible is limited, emergency adult LDLT should be considered one of the first-line treatment options in patients with ALF, especially in regions in which ALFs are caused by etiologies associated with poor outcome and the supply of organs is severely limited.
Hepatology 2010; 51:903-911.
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